{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:04:46Z","timestamp":1789574686837,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"DOI":"10.1007\/s10620-026-10232-0","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:08:49Z","timestamp":1789571329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Perioperative Immunosuppression on Post-surgical Outcomes in Patients with Inflammatory Bowel Disease"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2854-556X","authenticated-orcid":false,"given":"Nicholas P.","family":"Valle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Roney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaya","family":"Noorian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra C.","family":"Greb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny S.","family":"Sauk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary R.","family":"Kwaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berkeley N.","family":"Limketkai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"10232_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-020-0156-2","volume":"6","author":"G Roda","year":"2020","unstructured":"Roda G, Ng SC, Kotze PG et al. Crohn\u2019s disease Nat Rev Dis Primers 2020;6:22. https:\/\/doi.org\/10.1038\/s41572-020-0156-2.","journal-title":"Crohn\u2019s disease Nat Rev Dis Primers"},{"key":"10232_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, Siegmund B, Le Berre C et al. Ulcerative colitis Nat Rev Dis Primers 2020;6:74. https:\/\/doi.org\/10.1038\/s41572-020-0205-x.","journal-title":"Ulcerative colitis Nat Rev Dis Primers"},{"key":"10232_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41586-020-2025-2","volume":"578","author":"DB Graham","year":"2020","unstructured":"Graham DB, Xavier RJ. Pathway paradigms revealed from the genetics of inflammatory bowel disease. Nature 2020;578:527\u2013539. https:\/\/doi.org\/10.1038\/s41586-020-2025-2.","journal-title":"Nature"},{"key":"10232_CR4","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","volume":"160","author":"D Turner","year":"2021","unstructured":"Turner D, Ricciuto A, Lewis A et al. STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease initiative of the international organization for the study of IBD. Gastroenterology 2021;160:1570\u20131583. https:\/\/doi.org\/10.1053\/j.gastro.2020.12.031.","journal-title":"Gastroenterology"},{"key":"10232_CR5","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1093\/ecco-jcc\/jjae091","volume":"18","author":"H Gordon","year":"2024","unstructured":"Gordon H, Minozzi S, Kopylov U et al. ECCO guidelines on therapeutics in Crohn\u2019s disease: medical treatment. J Crohns Colitis 2024;18:1531\u20131555. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjae091.","journal-title":"J Crohns Colitis"},{"key":"10232_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","volume":"16","author":"T Raine","year":"2022","unstructured":"Raine T, Bonovas S, Burisch J et al. ECCO guidelines on therapeutics in ulcerative colitis: medical treatment. J Crohns Colitis 2022;16:2\u201317. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab178.","journal-title":"J Crohns Colitis"},{"key":"10232_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S2468-1253(19)30012-3","volume":"4","author":"NA Kennedy","year":"2019","unstructured":"Kennedy NA, Heap GA, Green HD et al. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn\u2019s disease: a prospective, multicentre, cohort study. Lancet Gastroenterol Hepatol 2019;4:341\u2013353. https:\/\/doi.org\/10.1016\/S2468-1253(19)30012-3.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10232_CR8","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S2468-1253(23)00154-1","volume":"8","author":"TL Parigi","year":"2023","unstructured":"Parigi TL, D\u2019Amico F, Abreu MT et al. Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting. Lancet Gastroenterol Hepatol 2023;8:853\u2013859. https:\/\/doi.org\/10.1016\/S2468-1253(23)00154-1.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10232_CR9","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/j.cgh.2020.10.039","volume":"19","author":"L Tsai","year":"2021","unstructured":"Tsai L, Ma C, Dulai PS et al. Contemporary risk of surgery in patients with ulcerative colitis and Crohn\u2019s disease: a meta-analysis of population-based cohorts. Clin Gastroenterol Hepatol 2021;19:2031-2045.e11. https:\/\/doi.org\/10.1016\/j.cgh.2020.10.039.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10232_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/gastro\/gow046","volume":"5","author":"AL Lightner","year":"2017","unstructured":"Lightner AL, Shen B. Perioperative use of immunosuppressive medications in patients with Crohn\u2019s disease in the new \u201cbiological era.\u201d Gastroenterol Rep (Oxf) 2017;5:165\u2013177. https:\/\/doi.org\/10.1093\/gastro\/gow046.","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10232_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/ecco-jcc\/jjac129","volume":"17","author":"S Sebastian","year":"2023","unstructured":"Sebastian S, Segal JP, Hedin C et al. ECCO topical review: roadmap to optimal peri-operative care in IBD. J Crohns Colitis 2023;17:153\u2013169. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjac129.","journal-title":"J Crohns Colitis"},{"key":"10232_CR12","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1093\/ibd\/izaa020","volume":"26","author":"CCY Law","year":"2020","unstructured":"Law CCY, Koh D, Bao Y, Jairath V, Narula N. Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis 2020;26:1796\u20131807. https:\/\/doi.org\/10.1093\/ibd\/izaa020.","journal-title":"Inflamm Bowel Dis"},{"key":"10232_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1053\/j.gastro.2022.03.057","volume":"163","author":"BL Cohen","year":"2022","unstructured":"Cohen BL, Fleshner P, Kane SV et al. Prospective cohort study to investigate the safety of preoperative tumor necrosis factor inhibitor exposure in patients with inflammatory bowel disease undergoing intra-abdominal surgery. Gastroenterology 2022;163:204\u2013221. https:\/\/doi.org\/10.1053\/j.gastro.2022.03.057.","journal-title":"Gastroenterology"},{"key":"10232_CR14","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1093\/ecco-jcc\/jjx095","volume":"11","author":"M Ferrante","year":"2017","unstructured":"Ferrante M, Schils N, Moens A et al. Perioperative use of vedolizumab is not associated with postoperative infectious complications in patients with ulcerative colitis undergoing colectomy. J Crohns Colitis 2017;11:1353\u20131361. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx095.","journal-title":"J Crohns Colitis"},{"key":"10232_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/jcag\/gwy013","volume":"1","author":"HH Shim","year":"2018","unstructured":"Shim HH, Ma C, Kotze PG et al. Preoperative Ustekinumab treatment is not associated with increased postoperative complications in Crohn\u2019s disease: a Canadian multi-centre observational cohort study. J Can Assoc Gastroenterol 2018;1:115\u2013123. https:\/\/doi.org\/10.1093\/jcag\/gwy013.","journal-title":"J Can Assoc Gastroenterol"},{"key":"10232_CR16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.20524\/aog.2021.0634","volume":"34","author":"R Garg","year":"2021","unstructured":"Garg R, Mohan BP, Ponnada S et al. Postoperative outcomes after preoperative ustekinumab exposure in patients with Crohn\u2019s disease: a systematic review and meta-analysis. Ann Gastroenterol 2021;34:691\u2013698. https:\/\/doi.org\/10.20524\/aog.2021.0634.","journal-title":"Ann Gastroenterol"},{"key":"10232_CR17","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.cgh.2025.01.032","volume":"23","author":"C Larson","year":"2025","unstructured":"Larson C, Berinstein JA, Tedesco N et al. Postoperative outcomes in tofacitinib-treated patients with acute severe ulcerative colitis undergoing colectomy. Clin Gastroenterol Hepatol 2025;23:2263-2271.e6. https:\/\/doi.org\/10.1016\/j.cgh.2025.01.032.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10232_CR18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0016-5085(03)00883-7","volume":"125","author":"FN Aberra","year":"2003","unstructured":"Aberra FN, Lewis JD, Hass D et al. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 2003;125:320\u2013327. https:\/\/doi.org\/10.1016\/S0016-5085(03)00883-7.","journal-title":"Gastroenterology"},{"key":"10232_CR19","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1111\/j.1572-0241.2008.01942.x","volume":"103","author":"V Subramanian","year":"2008","unstructured":"Subramanian V, Saxena S, Kang JY, Pollok RCG. Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery. Am J Gastroenterol 2008;103:2373\u20132381. https:\/\/doi.org\/10.1111\/j.1572-0241.2008.01942.x.","journal-title":"Am J Gastroenterol"},{"key":"10232_CR20","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.crohns.2014.07.007","volume":"8","author":"GC Nguyen","year":"2014","unstructured":"Nguyen GC, Elnahas A, Jackson TD. The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease. J Crohns Colitis 2014;8:1661\u20131667. https:\/\/doi.org\/10.1016\/j.crohns.2014.07.007.","journal-title":"J Crohns Colitis"},{"key":"10232_CR21","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1093\/ecco-jcc\/jjae089","volume":"18","author":"M Adamina","year":"2024","unstructured":"Adamina M, Minozzi S, Warusavitarne J et al. ECCO guidelines on therapeutics in Crohn\u2019s disease: surgical treatment. J Crohns Colitis 2024;18:1556\u20131582. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjae089.","journal-title":"J Crohns Colitis"},{"key":"10232_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/ecco-jcc\/jjab177","volume":"16","author":"A Spinelli","year":"2022","unstructured":"Spinelli A, Bonovas S, Burisch J et al. ECCO guidelines on therapeutics in ulcerative colitis: surgical treatment. J Crohns Colitis 2022;16:179\u2013189. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab177.","journal-title":"J Crohns Colitis"},{"key":"10232_CR23","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1097\/DCR.0000000000001716","volume":"63","author":"AL Lightner","year":"2020","unstructured":"Lightner AL, Vogel JD, Carmichael JC et al. The American society of colon and rectal surgeons clinical practice guidelines for the surgical management of Crohn\u2019s disease. Dis Colon Rectum 2020;63:1028\u20131052. https:\/\/doi.org\/10.1097\/DCR.0000000000001716.","journal-title":"Dis Colon Rectum"},{"key":"10232_CR24","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/DCR.0000000000002037","volume":"64","author":"SD Holubar","year":"2021","unstructured":"Holubar SD, Lightner AL, Poylin V et al. The American society of colon and rectal surgeons clinical practice guidelines for the surgical management of ulcerative colitis. Dis Colon Rectum 2021;64:783\u2013804. https:\/\/doi.org\/10.1097\/DCR.0000000000002037.","journal-title":"Dis Colon Rectum"},{"key":"10232_CR25","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1093\/ecco-jcc\/jjz083","volume":"13","author":"GC Nguyen","year":"2019","unstructured":"Nguyen GC, Du L, Chong RY, Jackson TD. Hypoalbuminaemia and postoperative outcomes in inflammatory bowel disease: the NSQIP surgical cohort. J Crohns Colitis 2019;13:1433\u20131438. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz083.","journal-title":"J Crohns Colitis"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10232-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10232-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10232-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:08:50Z","timestamp":1789571330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10232-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":25,"alternative-id":["10232"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10232-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None to report by all authors.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}